New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's effects eventually waned. But it's a very different ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...

Raytheon's Tucson operation is working on a composable motor aimed at addressing production bottlenecks in missile programs.

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced plans to launch advanced ...

Learn how Claude Code's new workflow feature reduces token tax, improves reliability, and automates complex developer tasks efficiently.

U.S. military contractors will need at least three years to replenish stockpiles of three key weapons systems used in the ...

Spyware attacks that target journalists, human rights defenders, and political dissidents have become common, and major tech companies now offer opt-in ...